Research progress of zoledronic acid combined with other anti-tumor methods in the treatment of tumor bone metastases

VernacularTitle:唑来膦酸联合其他抗肿瘤方法治疗肿瘤骨转移的研究进展
Author: Xiaowen DENG ¹ ; Qiang HUANG ; Qiuming GAO
Author Information

1. 730050,兰州总医院骨科
Keywords: Bone neoplasms/SC/DT; Diphosphonates/TU; Antineoplastic combined chemotherapy protocols; Review
From: Journal of Chinese Physician 2018;20(9):1427-1429
CountryChina
Language:Chinese
Abstract: Tumor bone metastasis is one of the common complications of advanced tumor and one of the signs of poor prognosis.There are many targeted drugs for bone metastasis in the clinic,which play a very important role in the antitumor treatment and prevention of bone related events.Among them,zoledronic acid,a representative bisphosphonate drug,has been extensively studied.It has been found that zoledronic acid combined with other anti-tumor therapies can more effectively inhibit the occurrence of tumor and bone-related events.This article reviews the latest research on zoledronic acid combined with other antitumor methods to guide clinical use and provide research ideas.